JPWO2023002011A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023002011A5
JPWO2023002011A5 JP2024503904A JP2024503904A JPWO2023002011A5 JP WO2023002011 A5 JPWO2023002011 A5 JP WO2023002011A5 JP 2024503904 A JP2024503904 A JP 2024503904A JP 2024503904 A JP2024503904 A JP 2024503904A JP WO2023002011 A5 JPWO2023002011 A5 JP WO2023002011A5
Authority
JP
Japan
Prior art keywords
chloro
piperazin
quinolyl
dihydrochloride
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024503904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527427A5 (https=
JP2024527427A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/070601 external-priority patent/WO2023002011A1/en
Publication of JP2024527427A publication Critical patent/JP2024527427A/ja
Publication of JP2024527427A5 publication Critical patent/JP2024527427A5/ja
Publication of JPWO2023002011A5 publication Critical patent/JPWO2023002011A5/ja
Pending legal-status Critical Current

Links

JP2024503904A 2021-07-23 2022-07-22 グラム陰性細菌排出ポンプ阻害剤 Pending JP2024527427A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21306032.0 2021-07-23
EP21306032 2021-07-23
PCT/EP2022/070601 WO2023002011A1 (en) 2021-07-23 2022-07-22 Gram-negative bacteria efflux pump inhibitors

Publications (3)

Publication Number Publication Date
JP2024527427A JP2024527427A (ja) 2024-07-24
JP2024527427A5 JP2024527427A5 (https=) 2025-07-11
JPWO2023002011A5 true JPWO2023002011A5 (https=) 2025-07-11

Family

ID=77564041

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503904A Pending JP2024527427A (ja) 2021-07-23 2022-07-22 グラム陰性細菌排出ポンプ阻害剤

Country Status (6)

Country Link
US (1) US20240327354A1 (https=)
EP (1) EP4373808A1 (https=)
JP (1) JP2024527427A (https=)
KR (1) KR20240057402A (https=)
CN (1) CN118076585A (https=)
WO (1) WO2023002011A1 (https=)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200024B1 (de) * 1985-04-30 1992-07-01 ARZNEIMITTELWERK DRESDEN GmbH 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
AU2001280091A1 (en) * 2000-08-01 2002-02-13 Wockhardt Limited Inhibitors of cellular efflux pumps of microbes
US7074794B2 (en) * 2000-08-10 2006-07-11 Mitsubishi Pharma Corporation Proline derivatives and the use thereof as drugs
JP2007507514A (ja) * 2003-09-30 2007-03-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キノキサリン化合物
EP1836189A1 (en) * 2005-01-06 2007-09-26 AstraZeneca AB Novel pyridine compounds
EP1987827A1 (en) * 2006-02-20 2008-11-05 Takeda Pharmaceutical Company Limited Novel pharmaceutical
TW200815426A (en) * 2006-06-28 2008-04-01 Astrazeneca Ab New pyridine analogues II 333
MX2009000577A (es) * 2006-07-14 2009-03-09 Schering Corp Compuestos de piperazina sustituida heterociclica con actividad antagonista de cxcr3.
TW201204727A (en) * 2010-03-10 2012-02-01 Kalypsys Inc Heterocyclic inhibitors of histamine receptors for the treatment of disease
JP2011246461A (ja) * 2010-04-27 2011-12-08 Mitsubishi Tanabe Pharma Corp 新規アミド誘導体を含有する医薬組成物
EA201390476A1 (ru) * 2010-09-28 2013-08-30 Бристол-Майерс Сквибб Компани Новые пиперазиновые аналоги с замещенными гетероарильными группами в качестве противовирусных средств широкого применения против гриппа
EP3371164B1 (en) * 2015-11-06 2022-03-16 Neurocrine Biosciences, Inc. N-[2-(1-benzylpiperidin-4-yl)ethyl]-4-(pyrazin-2-yl)-piperazine-1-carboxamide derivatives and related compounds as muscarinic receptor 4 (m4) antagonists for treating neurological diseases
WO2017097927A1 (en) * 2015-12-11 2017-06-15 Syngenta Participations Ag Pesticidally active 1,2,4-triazole derivatives
US20190119236A1 (en) * 2016-02-23 2019-04-25 Portola Pharmaceuticals, Inc. Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
WO2017160069A1 (ko) * 2016-03-15 2017-09-21 재단법인 의약바이오컨버젼스연구단 신규한 벤젠설폰아미드 유도체 및 이의 용도
MX393606B (es) * 2016-12-30 2025-03-19 Mitobridge Inc Inhibidores de poli-adp ribosa polimerasa (parp)
US11518764B2 (en) * 2018-02-06 2022-12-06 Ontario Institute For Cancer Research (Oicr) Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interaction
JP7637328B2 (ja) * 2019-02-07 2025-02-28 ベイジーン リミテッド Tlr7アゴニストとしてのイミダゾ[2,1-f][1,2,4]トリアジン-4-アミン誘導体
WO2021067859A1 (en) * 2019-10-03 2021-04-08 Tenaya Therapeutics, Inc. 5-fluoronicotinamide derivatives and uses thereof
WO2021127333A1 (en) * 2019-12-19 2021-06-24 Casma Therapeutics, Inc. Trpml modulators

Similar Documents

Publication Publication Date Title
JP2019077725A5 (https=)
RU2386630C2 (ru) Соединения и композиции в качестве ингибиторов протеинтирозинкиназы
JP2013517283A5 (https=)
RU2009147733A (ru) Пиридилпиперидновые антагонисты рецептора орексинов
CN102971291B (zh) 新型酰胺衍生物及其作为药物的用途
JP2007508346A5 (https=)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2018527336A5 (https=)
JP2006500369A5 (https=)
RU2012127790A (ru) Индуцирующие апоптоз агенты для лечения рака и иммунных и аутоиммунных заболеваний
JP2006500348A5 (https=)
JP2008500336A5 (https=)
RU2008110949A (ru) Соединения и композиции-иммуносупрессанты
JP2007523181A5 (https=)
RU2006127572A (ru) Полигетероциклические соединения и их применение в качестве антагонистов метаботропного рецептора глутамата
RU2004125146A (ru) Новые соединения
RU2006126974A (ru) Амидное производное и лекарственное средство
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
RU2009144191A (ru) Имидазопиридиновые ингибиторы киназ
RU2012154308A (ru) Пиперидинил-замещенные лактамы как модуляторы gpr119
RU2010116352A (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
JP2014523400A5 (https=)
JP2017512184A5 (https=)
JP2010540462A5 (https=)
JPWO2021170109A5 (https=)